Stocks
Ligand Pharmaceuticals IncorporatedLGND
NASDAQHealthcareBiotechnology$202.91-4.05%
Specializing in small-molecule therapeutics, this biopharmaceutical firm develops and licenses drug discovery technologies to pharmaceutical partners. Investors monitor its royalty-based revenue model and pipeline of partnered programs targeting areas like oncology and metabolic diseases.
Market Cap: $4.0B52W Range: $93.58 – $227.92
Congressional Interest in Ligand Pharmaceuticals Incorporated (LGND)
5 members of Congress have disclosed 13 trades in Ligand Pharmaceuticals Incorporated (LGND), a Healthcare company. The buy/sell breakdown shows 10 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
5
Buys
10
Sells
3
Who in Congress Is Trading LGND?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-01-15 | Gilbert Cisneros | buy | $1K – $15K |